No significant change in tumor cell proliferation or the percentage of cleaved PARP-positive cells was observed in low to undetectable FGF19-expressing HCC10-0505, HCC26-0808A, or HCC01-1214 tumors following FGF401 treatment (Supplementary Fig. 2b). The gene discussed is FGF19; the disease is neoplasm.